Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:17   Issue: 2
Pp: 99-99
William Cho
DOI: 10.2174/156800961702170109213433

Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review

Volume:17   Issue: 2
Pp: 100-108
Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang
DOI: 10.2174/1568009616666160112105824

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors

Volume:17   Issue: 2
Pp: 109-121
Alessandro Federico, Silvia Zappavigna, Marcello Dallio, Gabriella Misso, Francesco Merlino, Carmela Loguercio, Ettore Novellino, Paolo Grieco and Michele Caraglia
DOI: 10.2174/1568009616666160621101248

Current Development of ROS-Modulating Agents as Novel Antitumor Therapy

Volume:17   Issue: 2
Pp: 122-136
Nan Wang, Yue Wu, Jinlei Bian, Xue Qian, Hongzhi Lin, Haopeng Sun, Qidong You and Xiaojin Zhang
DOI: 10.2174/1568009616666160216125833

Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

Volume:17   Issue: 2
Pp: 158-168
Mounia Guerram, Aida Mejda Hamdi, Lu-Yong Zhang and Zhenzhou Jiang
DOI: 10.2174/1568009616666160603123014

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Volume:17   Issue: 2
Pp: 169-176
Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou
DOI: 10.2174/1568009616666160331124759

CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma

Volume:17   Issue: 2
Pp: 191-197
Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao
DOI: 10.2174/1568009616666160426125058